key: cord-0901290-nyzioxf1 authors: Xu, Hong; Garcia-Ptacek, Sara; Annetorp, Martin; Cederholm, Tommy; Engel, Georg; Engström, Malin; Erlandsson, Håkan; Julius, Charlotte; Kivipelto, Miia; Lundberg, Lars Göran; Metzner, Carina; Sandberg, Linda; Nyvang, Josefina Skogö; Öberg, Carina Sühl; Åkesson, Elisabet; Religa, Dorota; Eriksdotter, Maria title: Decreased mortality over time during the first wave in patients with COVID-19 in geriatric care – data from the Stockholm GeroCovid Study date: 2021-06-12 journal: J Am Med Dir Assoc DOI: 10.1016/j.jamda.2021.06.005 sha: 5aa023310a5e1d36d15cf74c1982b78ab1f43dbe doc_id: 901290 cord_uid: nyzioxf1 Objective To describe temporal changes in treatment, care, and short-term mortality outcomes of geriatric patients during the first wave of the COVID-19 pandemic. Design Observational study. Setting and Participants Altogether 1,785 patients diagnosed with COVID-19 and 6,744 hospitalized for non-COVID-19 causes at seven geriatric clinics in Stockholm from March 6th to July 31st, 2020 were included. Methods Across admission month, patient vital signs and pharmacological treatment in relationship to risk for in-hospital death were analyzed using the Poisson regression model. Incidence rates (IR) and Incidence rate ratios (IRR) of death are presented. Results In patients with COVID-19, the IR of mortality were 27%, 17%, 10%, 8%, and 2% from March to July, respectively, after standardization for demographics and vital signs. Compared with patients admitted in March, the risk of in-hospital death decreased by 29%(IRR 0.71, 95% CI 0.51-0.99) in April, 61%(0.39, 0.26-0.58) in May, 68%(0.32, 0.19-0.55) in June and 86%(0.14, 0.03-0.58) in July. The proportion of patients admitted for geriatric care with oxygen saturation <90% decreased from 13% to 1%, which partly explains the improvement of COVID-19 patient survival. In non-COVID-19 patients during the pandemic, mortality rates remained relatively stable (IR 1.3%-2.3%). Compared with non-COVID-19 geriatric patients, the IRR of death declined from 11 times higher (IRR 11.7, 95%CI 6.11-22.3) to 1.6 times (2.61,0.50-13.7) between March and July in patients with COVID-19. Conclusions and Implications Mortality risk in geriatric patients from the Stockholm region declined over time throughout the first pandemic wave of COVID-19. The improved survival rate over time was only partly related to improvement in saturation status at the admission of the patients hospitalized later throughout the pandemic. Lower incidence during the later months could have led to less severe hospitalized cases driving down mortality. patients hospitalized later throughout the pandemic. Lower incidence during the later months 24 could have led to less severe hospitalized cases driving down mortality. Stockholm region, which accounts for 20% of the Swedish population was severely affected 29 during the pandemic and has suffered a high mortality rate among older patients 1 . In the present study, we included all patients who were admitted to seven geriatric clinics in 54 Stockholm, Sweden, from March 6 th to August 31 st , 2020. The geriatric clinics in the Stockholm 55 area enroll patients who are biologically aged with reduced physical and/or cognitive function 56 and multiple comorbidities and in need of geriatric medical care and/or rehabilitation. We 57 excluded patients 1) hospitalized less than 24 hours (n=7) or 2) missing information regarding 58 initial vital signs (n=34) or 3) with admission date after July 31, 2020 (n=12). A total of 1,785 59 patients hospitalized with the COVID-19 diagnosis were included, together with 6,744 patients 60 with non-COVID-19 diagnoses also hospitalized during the same time period (eFigure 1). 63 The COVID-19 diagnosis was based either on a positive reverse transcriptase-polymerase chain 64 reaction (RT-PCR) analysis from nasopharyngeal swabs or for symptomatic patients with a 65 negative RT-PCR but with a typical clinical diagnosis (including a consultation with a specialist 66 in infectious diseases) and a CT scan of the chest with typical COVID-19 findings (ground-glass 67 opacities). Information regarding patient demographics, initial vital signs, medications, diagnoses 68 at discharge, and in-hospital death were collected through the hospital electronic health records. Since the month for those admitting in March 2020 was not a full month, we also set the 83 secondary exposure as to how many days into the pandemic (between March 6 and July 31) the 84 day of admission to the geriatric clinic for each patient occurred. This number was calculated as 85 the difference between the date of admission for each given patient minus the date of admission 86 of the first patient in the cohort. We then evaluated the incidence of in-hospital death using standardized incidence rates with 95% 101 confidence intervals (95% CI) via logistic regression models to account for differences in patient 102 characteristics over admission month 11 . Stepwise adjustment for explanatory variables included (i) 103 age and sex; (ii) and initial vital signs. Via Poisson regression models, we explored whether adjustment for implementation of 106 treatments modified the risk of in-hospital death. To assess the effect of admission month on this 107 outcome, similar stepwise adjustments were performed for (i) age and sex; (ii) initial vital signs; 108 and (iii) medical treatment. Results were reported as incidence rate ratios (IRRs) and 95% CI. The days into the pandemic for each patient were introduced as a cubic spline with knots at 10, 111 50, 90 percentiles. The model was adjusted for age, sex, initial vital signs, and medications. Several sensitivity and subgroup analyses were performed to test the robustness of the results. First, to explore the possibility of detection bias, we excluded patients who were transferred to 115 other departments or hospitals (n=152, 8.5% of all patients). Second, we explored the 116 associations between admission month and in-hospital death in pre-specified strata, including sex, 117 age, initial saturation (<90% and ≥90%), and their interactions. In addition, the role of low 118 J o u r n a l P r e -p r o o f saturation (<90%) and selected treatment in this association were tested through mediation 119 analyses. The mediating effect was analyzed using the generalized structural equation model 12 . Finally, survival trends were also compared against non-COVID-19 patients admitted during the 122 corresponding period, in order to account for mortality changes in the underlying background 123 population. There are no missing variables to report, and all analyses were performed using R (https://www.r- 133 We identified 1,785 patients diagnosed with COVID-19 from seven geriatric clinics in Stockholm 134 from March 6 th to July 31 st ; 1675 patients had a positive COVID-19 RT-PCR (94%), while 110 135 (6%) had negative RT-PCR but were diagnosed with COVID-19 based on typical symptoms and 136 typical findings on a CT scan with no other explanation of the symptoms. 53% were women and 137 the mean age was 83±9 years. Mean initial oxygen saturation was 95±6%, 6% of patients had low 138 saturation (<90%), and the rest had saturation ≥90 %. Forty-seven percent of COVID-19 patients 139 were treated with angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin receptor 140 J o u r n a l P r e -p r o o f blockers (ARBs), 51% used β-blockers, 29% used calcium-channel blockers, 37% were 141 prescribed statins and 53% used diuretics. LMWHs were used in 45%, non-vitamin-K antagonist 142 oral anticoagulants (NOACs) in 30%, warfarin in 7%, antibiotics in 39%, and glucocorticoids in 143 17% of COVID-19 patients within the first 24h of admission. In addition to COVID-19, the most 144 common diagnoses were hypertension (46%), followed by diabetes (36%), atrial fibrillation 145 (31%), heart failure (23%), pulmonary disease (19%), chronic kidney disease (17%) and 146 dementia (16%) ( Table 1) . Across the 1-month blocks, the proportion of patients arriving at the hospital with low saturation 149 (<90%) decreased over time from 13% in March to 1% in July, and the use of antibiotics 150 decreased from 48% to 38%, whereas prescription of LMWHs increased from 17% in March to 151 41% in July and NOACs from 26% to 42%. However, there were no differences in age, sex, and 152 other medication use over time (Table 1, Figure 1A ). Changes in in-hospital death 155 From March to July, we observed a decreased incidence rate in in-hospital death in the 156 unadjusted model. After standardization for age, gender, and vital signs, the in-hospital death was 157 27% (March), 17% (April), 10% (May), 8% (June) and 2% (July, Table 2, Figure 1B ). Table 2) . Low saturation at admission, older age, male sex, and use of antibiotics were 163 associated with in-hospital death (Figure 2 ). When modeling time as a continuous metric using cubic splines, a declining exponential 166 association was observed between day into the pandemic of the day of admission for each patient 167 and in-hospital death. Patients admitted in the later stage of the pandemic had a lower mortality 168 risk compared with patients admitted in the early stages (Figure 3) . A similar decreasing trend was observed when we excluded 152 patients who were transferred to 172 other departments or hospitals in sensitivity analyses (eTable 1). Among sex and age subgroups, men and older patients died more frequently in-hospital but 175 presented a similar decrease in mortality over time. When stratifying for initial saturation (<90%, 176 ≥90%), associations with decreasing mortality over time were observed in patients with normal 177 saturation (≥90%); but no association with decreasing mortality was seen in patients with 178 saturation <90% (eTable 2, eFigure 2). The analyses revealed a significant interaction between 179 admission date and saturation at admission (p interaction =0.01). years, 58% men) observed an overall 60-day mortality decreased from 25% in March to 13% in 212 June 13 . A German study from 920 hospitals including 10,021 hospitalized COVID-19 patients 213 with median age 72 and 50% men, reported a change in mortality from end-February to mid- April of 28% to 19%, respectively 14 . In addition, a recent meta-analysis of COVID-19 patients 215 receiving ICU care (10,150 patients from 24 studies) showed that the pooled mortalities were 216 lower in May than in January (25% to 60%) 15, 16 . The reported mortality rate in our study is 217 similar to the two population studies described above 13, 14 , but, as expected, lower than the study 218 on patients in ICU 15, 16 . Interestingly, in non-COVID-patients mortality rates remained relatively 219 stable throughout the first pandemic wave, with only a slight increase in April. This may be 220 explained by an effect of the COVID-19 situation, when hospital bed shortages may have caused 221 only severely ill non-COVID-patients to be admitted. We observed a large decrease in the proportion of patients arriving at the geriatric clinics with low 270 saturation (<90%, from 13% to 1%) over time. In addition, low initial saturation was associated 271 with increased in-hospital death, which explained an 8% proportion of the difference in in-272 hospital mortality in our study. Previous studies showed that higher age, frailty, lower blood 60-day mortality decreased in the first wave following by an increase in the second wave 25, 26 . 287 This suggests that the mortality decrease in the first wave wasn't only due to improvements in 288 care. Strengths and limitations must be considered when interpreting the results of the present study. The main strength was the inclusion of a relatively large sample of hospitalized older patients 292 with COVID-19, with rich information of potential risk factors, confounders, as well as access to 293 health records during the hospital stay. One limitation is that we did not have data on discharge 294 outcomes and therefore reported in-hospital death. The mortality rate may thus be underestimated. Second, in our dataset, we did not have access to comorbidities, but discharge diagnoses served 296 as a proxy. To avoid reversed causality, these diagnoses were used to describe the population but Furthermore, the most vital older patients may have been treated in the ICU or infectious disease 305 wards instead of geriatric clinics and therefore may also not be a part of the study population. Thus, the in-hospital mortality of COVID-19 patients reported here is based on the large older 307 cohort who was admitted to geriatric care in geriatric clinics which did not include a substantial Hospital stay, days, (median, IQR) 9.0 (6.0, 14.0) 10.0 (6.0, 17.0) 9.0 (6.0, 14.0) 10.0 (7.0, 15.0) 9.0 (6.0, 13.0) 9.0 (6.0, 14.0) 0.21 Abbreviations: SD, standard deviation; IQR, interquartile range; SBP, Systolic blood pressure Diastolic blood pressure ACEI, angiotensin-401 converting enzyme inhibitors ARB, angiotensin receptor blockers; CCB, calcium channel blockers; NOAC, Non-vitamin-K antagonist oral 402 anticoagulant; LMWH, low molecular heparin; NSAID, nonsteroidal anti-inflammatory drug p-values were tested with the Jonckheere-Terpstra trend test for continuous data and with linear-by-linear trend test for categorical variables We thank all patients, caregivers, physicians, reporting units, and coordinators in this study. None of the authors declare any conflict of interest pertinent to the present work.